Amneal Pharmaceuticals (AMRX) Asset Utilization Ratio (2018 - 2026)
Amneal Pharmaceuticals (AMRX) posted Asset Utilization Ratio of 0.85 for Q2 2026, up 0.98% on a QoQ basis from 0.84 in Q1 2026, and up 1.38% year-over-year from 0.84 in Q2 2025.
Analysis
Amneal Pharmaceuticals (AMRX) Asset Utilization Ratio (2018 - 2026) Analysis & Trends
Amneal Pharmaceuticals has reported Asset Utilization Ratio for 9 years, with the latest figure at 0.85 in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio rose 1.38% year-over-year to 0.85 in Q2 2026; TTM through Jun 2026 was 0.85, a 1.38% increase from a year earlier, with the FY2025 full-year figure at 0.84, up 4.95% from the prior year.
- Asset Utilization Ratio was 0.85 for Q2 2026 at Amneal Pharmaceuticals, up from 0.84 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.85 in Q2 2026, with the low at 0.54 in Q2 2022.
- Average Asset Utilization Ratio over 5 years is 0.71, with a median of 0.73 recorded in 2024.
- The sharpest annual moves came in 2024 and 2026: Asset Utilization Ratio increased 20.03% in 2024, then advanced 1.38% in 2026.
- Over 5 years, Asset Utilization Ratio stood at 0.58 in 2022, then increased by 15.96% to 0.67 in 2023, then rose by 20.03% to 0.8 in 2024, then advanced by 3.36% to 0.83 in 2025, then grew by 2.73% to 0.85 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.85 (Q2 2026), 0.84 (Q1 2026), and 0.83 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 0.43 |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 0.41 |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 0.59 |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 0.85 |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 0.44 |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 0.23 |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 0.67 |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 0.43 |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 0.73 |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.85 |
| Mar 31, 2026 | 0.84 |
| Dec 31, 2025 | 0.83 |
| Sep 30, 2025 | 0.84 |
| Jun 30, 2025 | 0.84 |
| Mar 31, 2025 | 0.82 |
| Dec 31, 2024 | 0.80 |
| Sep 30, 2024 | 0.77 |
| Jun 30, 2024 | 0.75 |
| Mar 31, 2024 | 0.72 |
| Dec 31, 2023 | 0.67 |
| Sep 30, 2023 | 0.65 |
| Jun 30, 2023 | 0.63 |
| Mar 31, 2023 | 0.61 |
| Dec 31, 2022 | 0.58 |
| Sep 30, 2022 | 0.54 |
| Jun 30, 2022 | 0.54 |
| Mar 31, 2022 | 0.54 |
| Dec 31, 2021 | 0.53 |
| Sep 30, 2021 | 0.52 |